Oncolytic Biotechnology


Oncolytic Biotechnology is the study of oncolytic virus, the virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumour. Oncolytic viruses are thought not only to cause direct destruction of the tumour cells, but also to stimulate host anti-tumour immune responses.


 

    Related Conference of Oncolytic Biotechnology

    April 27-28, 2023

    26th World Congress on Advanced Biotechnology

    Barcelona, Spain
    June 27-28, 2023

    13th Annual Summit on Advanced Bionics

    Vienna, Austria
    June 28-29, 2023

    27th Global Congress on Biotechnology

    Paris, France
    July 10-11, 2023

    3rd World Congress on Food Science and Biotechnology

    Prague, Czech Republic
    September 25-26, 2023

    6th Annual Congress on Biosimilars

    Taipei, Taiwan
    October 23-24, 2023

    3rd International Conference on Bioprinting

    Los Angeles, USA
    October 23-24, 2023

    8th International summit on Biomanufacturing

    Los Angeles, USA
    October 23-24, 2023

    27th European Biotechnology Congress

    Rome, Italy
    November 21-22, 2023

    27th Biotechnology Congress: Research & Innovations

    Berlin, Germany

    Oncolytic Biotechnology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in